Tegaserod for Irritable Bowel Syndrome With Constipation in Women Younger Than 65 Years Without Cardiovascular Disease: Pooled Analyses of 4 Controlled Trials

INTRODUCTION: Tegaserod was the first US Food and Drug Administration–approved drug for irritable bowel syndrome with constipation (IBS-C) in women and was recently reapproved for use. Recognizing that clinical trials were performed almost 20 years ago, we performed an integrated analysis on patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Eric D., Lacy, Brian E., Chey, William D., Chang, Lin, Brenner, Darren M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315186/
https://www.ncbi.nlm.nih.gov/pubmed/34047303
http://dx.doi.org/10.14309/ajg.0000000000001313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8315186/
https://www.ncbi.nlm.nih.gov/pubmed/34047303
http://dx.doi.org/10.14309/ajg.0000000000001313

Ejemplares similares